Filing Flows › Pulse Biosciences (PLSE) › Q2 2026 › vs Q1 2026
Pulse Biosciences (PLSE) Q2 2026 vs Q1 2026 (quarter over quarter)
Pulse Biosciences's revenue rose $33K (+8%) from $401K in Q1 2026 to $434K in Q2 2026.
Pulse Biosciences, Q2 2026: revenue $434K, net loss $24.7M, operating cash flow −$18.7M. The chart draws each line against Q1 2026, the increases inside each band.
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $434K | $401K | $33K | +8% |
| Other income, net | $615K | $569K | $46K | +8% |
| Net loss | $24.7M | $18.6M | $6.1M | +33% |
| Costs & expenses | $25.7M | $19.6M | $6.2M | +31% |
| Operating costs | $25.7M | $19.6M | $6.2M | +31% |
| Cost of revenue | $273K | $370K | −$97K | -26% |
| Research & development | $17.0M | $12.6M | $4.4M | +35% |
| SG&A | $8.5M | $6.6M | $1.9M | +28% |
| Operating cash sources | $24.7M | $18.6M | $6.1M | +33% |
| Depreciation & amortization | $254K | $255K | −$1K | -0.4% |
| Share-based compensation | $5.0M | $1.9M | $3.1M | +160% |
| Working capital & other | $721K | $1.8M | −$1.1M | -60% |
| Cash used in operations | $18.7M | $14.6M | $4.1M | +28% |
| Net loss absorbed | $24.7M | $18.6M | $6.1M | +33% |
Questions
How much did Pulse Biosciences's revenue grow quarter over quarter in Q2 2026?
Pulse Biosciences's revenue rose $33K (+8%) from $401K in Q1 2026 to $434K in Q2 2026.